Charity warns of patient 'risk' under NICE diabetes guidance

Latest NICE guidance on the management of type-2 diabetes could leave patients ‘more at risk of developing serious complications’, the charity Diabetes UK has warned.

Stella Valerkou, senior policy officer at Diabetes UK, said that the charity was ‘disappointed' that NICE had failed to include tighter BP targets in its guidance.

The guidance, issued last week, recommends a BP target of less than 140/80mmHg for type-2 diabetics and a lower target of 130/80mmHg for diabetics with kidney, eye or cerebrovascular damage.

But Diabetes UK is calling for BP targets of 130/80mmHg and 125/75mmHg, in line with the Joint British Societies' guidelines (JBS2).

‘The impact of BP on complications is well known and Diabetes UK is concerned that this decision could leave patients more at risk of serious complications of the condition including heart disease, stroke and kidney disease,' said Ms Valerkou.

But Dr Brian Karet, diabetes lead for Bradford PCT, welcomed the NICE BP targets.
‘From a practical perspective these BP levels are fine. Patients are required to take a lot of medications in order to lower BP levels down to 140/80mmHg.

‘Setting an even tougher BP target could lead to some patients giving up.'
NICE has gone with the greatest body of evidence which supports BP targets of 140/80mmHg, said Dr Karet.

There is only limited evidence to support the JBS2 target, he added.

sanjay.tanday@haymarket.com

NICE website

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus